Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 242
Filtrar
Mais filtros

Intervalo de ano de publicação
1.
JAMA ; 330(3): 217-218, 2023 07 18.
Artigo em Inglês | MEDLINE | ID: mdl-37382929

RESUMO

This Viewpoint analyzes the scope and legal implications of tracking on hospital websites, including potential HIPAA and state privacy law violations, and suggests that hospitals limit such tracking.


Assuntos
Legislação Hospitalar , Tecnologia , Confidencialidade , Health Insurance Portability and Accountability Act , Hospitais , Privacidade , Estados Unidos , Internet/legislação & jurisprudência , Tecnologia/legislação & jurisprudência
3.
JAMA Netw Open ; 4(7): e2116551, 2021 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-34251442

RESUMO

Importance: As global jurisdictions shift toward cannabis legalization, 2 areas of public health importance relate to exposure to youth and to truthful promotion. Although Canada's Cannabis Act specifies many prohibitions related to cannabis promotion, no systematic monitoring or enforcement among licensed firms exists. Compliance with marketing regulations has effects beyond Canadian citizens because of the global outreach of websites and social media. Objectives: To evaluate compliance among licensed firms with the Cannabis Act and analyze trends among violations regarding promotional material. Design, Setting, and Participants: This cross-sectional study evaluated cannabis-licensed firms after cannabis legalization. Data were extracted from online public platforms, including company websites, Facebook, Instagram, and Twitter, from October 1, 2019, to March 31, 2020. Descriptive statistics, Poisson regression, and logistic regression were used to analyze the associations of covariates with promotion violations. Main Outcomes and Measures: The primary outcome was characterization of type and prevalence of promotion violations. Secondary outcomes were the role of various covariates (namely, licensed firm characteristics and online platforms) in the frequency and probability of violations. Hypotheses were formulated before data collection. Results: Among 261 licensed firms, 211 (80.8%) had an online platform, including 204 (96.7%) with websites, 128 (60.7%) with Facebook, 123 (58.3%) with Instagram, and 123 (58.3%) with Twitter. Of all licensed firms with an online platform, 182 (86.3%) had at least 1 violation. Compared with websites, the risk of violations was significantly higher on Facebook (rate ratio [RR], 1.24; 95% CI, 1.11-1.39) and Instagram (RR, 1.19; 95% CI, 1.05-1.34). The most common violations included lack of age restrictions, brand glamorization, and omission of risk information. With websites as the reference group, lack of age restrictions was approximately 15 times more likely to occur on Facebook (odds ratio [OR], 14.76; 95% CI, 8.06-27.05); the odds of an age restriction violation were also higher on Instagram (OR, 2.48; 95% CI, 1.43-4.32) and Twitter (OR, 4.03; 95% CI, 2.29-7.09). For unsubstantiated claims, the odds of violations were significantly decreased on Facebook (OR, 0.23; 95% CI, 0.11-0.48) and Instagram (OR, 0.28; 95% CI, 0.14-0.57). The odds of glamorization were associated with an increase on Instagram (OR, 2.90; 95% CI, 1.72-4.88). Conclusions and Relevance: In this cross-sectional study, widespread violations were observed in online Canadian cannabis promotion. To protect public health and safety amid legalization, decision-makers should make explicit federal regulation and enforcement regarding promotional activities of cannabis retailers. These results suggest that policy and enforcement of cannabis promotion in Canada would have an international impact, from ease of access to online media and downstream consequences of unregulated promotion.


Assuntos
Indústria Farmacêutica/estatística & dados numéricos , Fidelidade a Diretrizes/estatística & dados numéricos , Legislação de Medicamentos/estatística & dados numéricos , Marketing/legislação & jurisprudência , Maconha Medicinal , Canadá , Estudos Transversais , Indústria Farmacêutica/legislação & jurisprudência , Humanos , Internet/legislação & jurisprudência , Licenciamento em Farmácia/legislação & jurisprudência
4.
Plast Reconstr Surg ; 147(1): 231-238, 2021 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-33370071

RESUMO

BACKGROUND: Non-board-certified plastic surgeons performing cosmetic procedures and advertising as plastic surgeons may have an adverse effect on a patient's understanding of their practitioner's medical training and patient safety. The authors aim to assess (1) the impact of city size and locations and (2) the impact of health care transparency acts on the ratio of board-certified and non-American Board of Plastic Surgeons physicians. METHODS: The authors performed a systematic Google search for the term "plastic surgeon [city name]" to simulate a patient search of online providers. Comparisons of board certification status between the top hits for each city were made. Data gathered included city population, regional location, practice setting, and states with the passage of truth-in-advertising laws. RESULTS: One thousand six hundred seventy-seven unique practitioners were extracted. Of these, 1289 practitioners (76.9 percent) were American Board of Plastic Surgery-certified plastic surgeons. When comparing states with truth-in-advertising laws and states without such laws, the authors found no significant differences in board-certification rates among "plastic surgery" practitioners (88.9 percent versus 92.0 percent; p = 0.170). There was a significant difference between board-certified "plastic surgeons" versus out-of-scope practitioners on Google search between large, medium, and small cities (100 percent versus 92.9 percent versus 86.5; p < 0.001). CONCLUSIONS: Non-board-certified providers tend to localize to smaller cities. Truth-in-advertising laws have not yet had an impact on the way a number of non-American Board of Plastic Surgery-certified practitioners market themselves. There may be room to expand the scope of truth-in-advertising laws to the online world and to smaller cities.


Assuntos
Publicidade/estatística & dados numéricos , Marketing de Serviços de Saúde/estatística & dados numéricos , Conselhos de Especialidade Profissional/normas , Cirurgiões/estatística & dados numéricos , Cirurgia Plástica/normas , Publicidade/legislação & jurisprudência , Certificação/estatística & dados numéricos , Cidades/estatística & dados numéricos , Simulação por Computador , Técnicas Cosméticas/estatística & dados numéricos , Estudos Transversais , Humanos , Internet/legislação & jurisprudência , Internet/estatística & dados numéricos , Marketing de Serviços de Saúde/legislação & jurisprudência , Segurança do Paciente , Cirurgiões/legislação & jurisprudência , Cirurgiões/normas , Cirurgia Plástica/estatística & dados numéricos , Estados Unidos
5.
Nat Commun ; 11(1): 4738, 2020 09 29.
Artigo em Inglês | MEDLINE | ID: mdl-32994397

RESUMO

Wildlife trade is a key driver of the biodiversity crisis. Unregulated, or under-regulated wildlife trade can lead to unsustainable exploitation of wild populations. International efforts to regulate wildlife mostly miss 'lower-value' species, such as those imported as pets, resulting in limited knowledge of trade in groups like reptiles. Here we generate a dataset on web-based private commercial trade of reptiles to highlight the scope of the global reptile trade. We find that over 35% of reptile species are traded online. Three quarters of this trade is in species that are not covered by international trade regulation. These species include numerous endangered or range-restricted species, especially hotspots within Asia. Approximately 90% of traded reptile species and half of traded individuals are captured from the wild. Exploitation can occur immediately after scientific description, leaving new endemic species especially vulnerable. Pronounced gaps in regulation imply trade is having unknown impacts on numerous threatened species. Gaps in monitoring demand a reconsideration of international reptile trade regulations. We suggest reversing the status-quo, requiring proof of sustainability before trade is permitted.


Assuntos
Animais Selvagens , Comércio/legislação & jurisprudência , Espécies em Perigo de Extinção/legislação & jurisprudência , Internacionalidade/legislação & jurisprudência , Répteis , Animais , Comércio/economia , Espécies em Perigo de Extinção/economia , Internet/economia , Internet/legislação & jurisprudência
6.
Glob Health Promot ; 27(2): 109-113, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-30160602

RESUMO

In the United States of America, the Federal Communications Commission's repeal of the popular Open Internet Order (a.k.a 'net neutrality') has yielded pointed criticism from many different sectors, but it has yet to be examined for its potential effect on the public's health. In this commentary, we focus on the health implications of this policy change, considering expert opinion on the subject, past history, and global perspectives. We argue that the repeal of net neutrality has the potential to compromise health education and promotion efforts by widening the 'digital divide', thereby impairing health literacy and exacerbating health inequities. By negatively affecting people's ability to access, understand, and use unbiased, evidence-based health information to improve and maintain their health, the repeal of net neutrality may hinder the World Health Organization's vision of 'Health for All' by dismantling public protections in the name of corporate profit.


Assuntos
Educação em Saúde/métodos , Letramento em Saúde/estatística & dados numéricos , Internet/legislação & jurisprudência , Saúde da População/estatística & dados numéricos , Prática Clínica Baseada em Evidências/normas , Educação em Saúde/ética , Promoção da Saúde/métodos , Acessibilidade aos Serviços de Saúde/estatística & dados numéricos , Disparidades em Assistência à Saúde/tendências , Humanos , Internet/estatística & dados numéricos , Políticas , Estados Unidos/epidemiologia
8.
Gac Sanit ; 33(1): 85-88, 2019.
Artigo em Espanhol | MEDLINE | ID: mdl-29258688

RESUMO

OBJECTIVE: To assess the accessibility level of Internet appointment scheduling in primary care and the fulfilment of the requirements of Spanish legislation. METHOD: Descriptive study of the accessibility of 18 web sites corresponding to the autonomic health services responsible for Internet appointment scheduling for primary health care services. The level of web accessibility was evaluated by means of five automated tools. RESULTS: Only six websites self-declared to be in compliance with level AA of WCAG 2.0. The level of web accessibility according to the legal requirements in Spain is low. The evaluation tools identified the main errors to be corrected. CONCLUSIONS: Most of the autonomic health services responsible for Internet appointment scheduling in primary care need to improve their level of web accessibility and ensure that it complies with Spanish legislation.


Assuntos
Agendamento de Consultas , Internet , Atenção Primária à Saúde , Acessibilidade aos Serviços de Saúde/legislação & jurisprudência , Humanos , Internet/legislação & jurisprudência , Espanha
9.
Appl Physiol Nutr Metab ; 44(1): 74-82, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30273499

RESUMO

Marketing unhealthy foods and beverages to children (M2K) fosters poor dietary patterns, increasing obesity and noncommunicable disease risk. Federal restrictions on M2K have been under development in Canada since 2016; however, at present, M2K is mostly self-regulated by food companies. This study aimed to compare M2K on Canadian websites of food companies with and without voluntary policies or commitments in this area. A systematic content analysis of company websites was conducted in spring/summer 2017 for major packaged food (n = 16), beverage (n = 12), and restaurant chain (n = 13) companies in Canada. M2K policies were sourced from company websites and published corporate documents. Sixteen companies (43%) reported national and/or global M2K policies, while 21 companies (57%) had no published policies. The websites of Canadian companies (n = 154) were scanned for child-directed products and marketing; type and frequency of marketing techniques were recorded. Child-directed marketing appeared on 19 websites of 12 companies (32%), including 9 companies with M2K policies. Websites featured products with unconventional flavours, colours, shapes, or child-oriented packaging, and used promotional characters, contests, games, activities, or lettering and graphics appealing to children. The nutritional quality of products marketed to children was evaluated using a nutrient profile model developed by Health Canada for proposed M2K regulations. Of the 217 products marketed to children, 97% exceeded Health Canada's proposed ∼5% Daily Value threshold for saturated fat, sodium, and/or sugars, 73% of which were products from 9 companies with policies. These findings highlight the limitations of self-regulation in restricting M2K on food company websites, reinforcing the need for government regulations.


Assuntos
Comportamento Infantil , Dieta/efeitos adversos , Publicidade Direta ao Consumidor/legislação & jurisprudência , Comportamento Alimentar , Indústria Alimentícia/legislação & jurisprudência , Internet/legislação & jurisprudência , Política Nutricional/legislação & jurisprudência , Obesidade Infantil/prevenção & controle , Formulação de Políticas , Canadá , Criança , Fenômenos Fisiológicos da Nutrição Infantil , Regulamentação Governamental , Humanos , Valor Nutritivo , Obesidade Infantil/diagnóstico , Obesidade Infantil/fisiopatologia , Obesidade Infantil/psicologia , Medição de Risco , Fatores de Risco , Volição
12.
J Behav Addict ; 7(3): 503-517, 2018 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-28859487

RESUMO

BACKGROUND AND AIMS: Empirical research into problematic video game playing suggests that overuse might cause functional and psychological impairments for a minority of gamers. Therefore, the need for regulation in the case of video games (whether governmental or self-imposed) has arisen but has only been implemented in a few countries around the world, and predominantly in Asia. This paper provides a systematic review of current and potential policies addressing problematic gaming. METHODS: After conducting a systematic search in the areas of prevention, treatment, and policy measures relating to problematic Internet and video game use, papers were selected that targeted problematic gaming policies (N = 12; six in English and six in Korean). These papers served as the basis of this review. RESULTS: Policies were classified into three major groups: (i) policy measures limiting availability of video games (e.g., shutdown policy, fatigue system, and parental controls), (ii) measures aiming to reduce risk and harm (e.g., warning messages), and (iii) measures taken to provide help services for gamers. Beyond the attempt to classify the current and potential policy measures, the authors also tried to evaluate their efficiency theoretically and (if data were available) empirically. DISCUSSION AND CONCLUSIONS: Overall, it appears that although several steps have been taken to address problematic video game playing, most of these steps were not as effective as expected, or had not been evaluated empirically for efficacy. The reason for this may lie in the fact that the policies outlined only addressed or influenced specific aspects of the problem instead of using a more integrative approach.


Assuntos
Comportamento Aditivo/prevenção & controle , Comportamento Aditivo/terapia , Política de Saúde , Jogos de Vídeo/legislação & jurisprudência , Humanos , Internet/legislação & jurisprudência
13.
Clin Pharmacol Ther ; 104(5): 1016-1021, 2018 11.
Artigo em Inglês | MEDLINE | ID: mdl-29271014

RESUMO

The Food and Drug Administration's expanded access program allows patients with serious or immediately life-threatening conditions to seek access to experimental drugs and treatments from their manufacturers. The 21st Century Cures Act of 2016 sought to increase the transparency of manufacturers' approaches to expanded access by requiring public listing of five key pieces of information about their expanded access programs: 1) relevant contact information, 2) procedures for making requests, 3) general criteria used to evaluate requests, 4) length of time anticipated to acknowledge receipt of requests, and 5) a reference to pertinent information on ClinicalTrials.gov. Manufacturers were given 60 days from the Act's enactment, or until February 11, 2017, to post this information. We reviewed a sample of pharmaceutical manufacturers' expanded access policies to determine what information is readily available to patients online, including assessing whether the information described in the Act is available.


Assuntos
Acesso à Informação/legislação & jurisprudência , Ensaios de Uso Compassivo/legislação & jurisprudência , Indústria Farmacêutica/legislação & jurisprudência , Política de Saúde/legislação & jurisprudência , Acessibilidade aos Serviços de Saúde/legislação & jurisprudência , United States Food and Drug Administration/legislação & jurisprudência , Ensaios de Uso Compassivo/normas , Bases de Dados Factuais , Indústria Farmacêutica/normas , Fidelidade a Diretrizes , Guias como Assunto , Acessibilidade aos Serviços de Saúde/normas , Humanos , Internet/legislação & jurisprudência , Formulação de Políticas , Fatores de Tempo , Estados Unidos , United States Food and Drug Administration/normas
15.
Eur J Hum Genet ; 25(8): 908-917, 2017 08.
Artigo em Inglês | MEDLINE | ID: mdl-28703222

RESUMO

The declining cost of DNA sequencing has been accompanied by a proliferation of companies selling 'direct-to-consumer genetic testing' (DTC-GT) services. Many of these are marketed online as tools for enabling citizens to make more informed decisions about their health, wellness and lifestyle. We assessed the 'information for consumers' provided by these companies at the prepurchase stage, which could influence initial decisions to part with money, data or tissue samples. A scoping exercise revealed 65 DTC-GT companies advertising their services online to consumers in the United Kingdom, of which 15 met our inclusion criteria. We benchmarked their consumer information against the good practice principles developed by the UK Human Genetics Commission (HGC). No provider complied with all the HGC principles and overall levels of compliance varied considerably. Although consent for testing was discussed by all but one company, information about data reuse for research or other purposes was often sparse and consent options limited or unclear. Most did not provide supplementary support services to help users better understand or cope with the implications of test results. We provide recommendations for updating the preconsumer transparency aspects of the HGC guidelines to ensure their fitness-for-purpose in this rapidly changing market. We also recommend improving coordination between relevant governance bodies to ensure minimum standards of transparency, quality and accountability. Although DTC-GT has many potential benefits, close partnership between consumers, industry and government, along with interdisciplinary science input, are essential to ensure that these innovations are used ethically and responsibly.


Assuntos
Publicidade/normas , Triagem e Testes Direto ao Consumidor/normas , Testes Genéticos/normas , Publicidade/economia , Publicidade/legislação & jurisprudência , Publicidade/métodos , Triagem e Testes Direto ao Consumidor/economia , Triagem e Testes Direto ao Consumidor/ética , Testes Genéticos/economia , Testes Genéticos/ética , Internet/ética , Internet/legislação & jurisprudência , Internet/normas , Reino Unido
16.
J Law Med ; 25(1): 124-135, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-29978628

RESUMO

Pro-anorexia websites promote anorexia as a positive lifestyle choice. They provide tips to become anorexic and maintain anorexia and diets that people who are anorexic can follow. France became the first country in the world to pass legislation that criminalises the publication of pro-anorexia websites. This article considers the ways that the civil and criminal law in Western Australia can deal with the publishers of pro-anorexia websites. It argues that the law in Western Australia would be unlikely to apply to publishers of pro-anorexia websites, except in the most extreme cases, and it generally cautions against legislative intervention in this area.


Assuntos
Anorexia , Internet/legislação & jurisprudência , Promoção da Saúde , Humanos , Controle Social Formal , Austrália Ocidental
20.
Issue Brief Health Policy Track Serv ; 2016: 1-74, 2016 Dec 27.
Artigo em Inglês | MEDLINE | ID: mdl-28252887

Assuntos
Aprovação de Drogas/legislação & jurisprudência , Indústria Farmacêutica/legislação & jurisprudência , Regulamentação Governamental , United States Food and Drug Administration , Animais , Medicamentos Biossimilares , Ensaios Clínicos como Assunto , Comércio/legislação & jurisprudência , Qualidade de Produtos para o Consumidor/legislação & jurisprudência , Meios de Contraste , Aprovação de Equipamentos/legislação & jurisprudência , Suplementos Nutricionais/efeitos adversos , Composição de Medicamentos , Rotulagem de Medicamentos , Resistência Microbiana a Medicamentos , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Medicamentos Genéricos , Drogas em Investigação , Sistemas Eletrônicos de Liberação de Nicotina/efeitos adversos , Honorários Farmacêuticos , Fraude , Humanos , Internet/legislação & jurisprudência , Aplicação de Novas Drogas em Teste , Medicamentos sem Prescrição , Transtornos Relacionados ao Uso de Opioides , Produção de Droga sem Interesse Comercial/legislação & jurisprudência , Uso Indevido de Medicamentos sob Prescrição , Medicamentos sob Prescrição , Controle de Qualidade , Doenças Raras/tratamento farmacológico , Minorias Sexuais e de Gênero , Prevenção do Hábito de Fumar , Produtos do Tabaco/legislação & jurisprudência , Tabaco sem Fumaça/efeitos adversos , Estados Unidos , Vaping/efeitos adversos , Drogas Veterinárias , Infecção por Zika virus/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA